Planet 13 Holdings (PLNH) Cash from Operations (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Cash from Operations came in at 172823.0 in Q1 2026, up 96.67% year-on-year from 87874.85 in Q1 2025, and up 95.23% on a QoQ basis from 3621005.0 in Q4 2025.
Planet 13 Holdings (PLNH) Cash from Operations (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Cash from Operations data on file, last reported at 172823.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 96.67% year-over-year to 172823.0 in Q1 2026; TTM through Mar 2026 was 9175671.0, a 731.58% decrease from a year earlier, with the FY2025 full-year figure at 14191888.0, down 372.35% from the prior year.
- Cash from Operations for Q1 2026 stood at 172823.0, up from 3621005.0 in the prior quarter.
- Over the last five years, Cash from Operations for PLNH reached as high as 5193872.0 in Q2 2024 and fell as low as 7346140.0 in Q1 2023.
- Historically, Cash from Operations has averaged 1644881.12 across 5 years, with a median of 1431880.0 in 2024.
- Across the five-year window, Cash from Operations slumped 6643.5% in 2022 and soared 385.04% in 2024, its largest moves.
- Year by year, Cash from Operations stood at 2000534.0 in 2022, then surged by 57.09% to 858435.0 in 2023, then tumbled by 66.8% to 1431880.0 in 2024, then tumbled by 152.88% to 3621005.0 in 2025, then soared by 95.23% to 172823.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 172823.0 in Q1 2026, 3621005.0 in Q4 2025, and 4154346.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | -172,823.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -172,823.00 |
| Mar 31, 2026 | -172,823.00 |
| Dec 31, 2025 | -3.62 Mn |
| Dec 31, 2025 | -3.62 Mn |
| Sep 30, 2025 | -4.15 Mn |
| Sep 30, 2025 | -4.15 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Mar 31, 2025 | -5.19 Mn |
| Mar 31, 2025 | -5.19 Mn |
| Dec 31, 2024 | -1.43 Mn |
| Dec 31, 2024 | -1.43 Mn |
| Sep 30, 2024 | 2.88 Mn |
| Sep 30, 2024 | 2.88 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Mar 31, 2024 | -1.43 Mn |
| Mar 31, 2024 | -1.43 Mn |
| Dec 31, 2023 | -858,435.00 |
| Dec 31, 2023 | -858,435.00 |